U.S. Commercial Services Stock News

Pebblebrook Hotel Trust (PEB) has caught investor attention after a strong recent run, with the stock showing double digit total returns over the past month and the past 3 months from a US$14.08 close. See our latest analysis for Pebblebrook Hotel Trust. That recent strength builds on a 21.9% year to date share price return, while the 1 year total shareholder return of 54.59% contrasts with a 5 year total shareholder return decline of 39.5%, indicating momentum has picked up only relatively...

If you are wondering whether Westinghouse Air Brake Technologies at around US$264.95 is still a sensible entry point or if most of the value is already reflected in the price, this article breaks that question down clearly. The stock has delivered a 39.1% return over the last year, with 22.5% year to date, 3.5% over the last 30 days and a 0.8% decline in the last week. This mix can hint at both enthusiasm and shifting views on risk. Recent coverage has focused on the company as a key name in...

Jones Lang LaSalle (NYSE:JLL) reported record Q1 results, highlighting the role of its long running investments in AI and data platforms. The company detailed new and existing capital commitments to green and decarbonization initiatives, including a decarbonization fund launched with Shell. Management framed these moves as part of a broader shift in JLL's business model toward technology driven productivity, market share focus, and sustainability led services. For investors watching...

In April 2026, AtaiBeckley Inc. reported expanded Phase 2a data showing its oral R-MDMA candidate EMP-01 produced clinically meaningful, statistically significant improvements in adults with Social Anxiety Disorder across multiple symptom scales, with no severe or serious adverse events and high patient retention. A distinctive aspect of these results is that EMP-01 delivered robust benefits in fear, avoidance, and real-world social functioning without adjunctive psychotherapy, highlighting...

If you are wondering whether Kimberly-Clark at around US$97.67 offers good value today, the key question is how its current price lines up with its underlying fundamentals. The stock has seen mixed returns recently, with a 0.1% move over 30 days, a 3.7% decline year to date and a 21.7% decline over the past year, which can change how investors view both its potential and its risks. Recent coverage has focused on how established consumer brands like Kimberly-Clark are being reassessed by the...

ResMed (RMD) has put up another solid quarter, with Q2 2026 revenue at about US$1.4b and basic EPS of US$2.69, while the trailing 12 month figures sit at US$5.4b of revenue and EPS of US$10.16. Over the past six reported quarters, revenue has moved from US$1,224.5m in Q1 2025 to US$1,422.8m in Q2 2026 and basic EPS has shifted from US$2.12 to US$2.69. This gives a clear view of the top line and per share earnings trend across the recent reporting run. With trailing 12 month earnings up 19%...

First Solar (FSLR) just reported record first quarter 2026 results, with earnings per share beating expectations and net sales of US$1.04b. The company kept its full year guidance unchanged, which many investors watch closely. See our latest analysis for First Solar. The earnings beat helped shift sentiment after a weak start to the year, with the share price up 4.86% in the last session and a 7 day share price return of 9.26%. However, year to date the share price return is still down...

Last week saw the newest first-quarter earnings release from Omnicom Group Inc. ( NYSE:OMC ), an important milestone in...

Why NetScout Systems Is On Investors’ Radar NetScout Systems (NTCT) has drawn fresh attention after recent share price moves, with the stock posting returns of 5.2% over the past month and 22.2% over the past 3 months. Those gains have arrived alongside a value score of 4 and an indicated intrinsic discount of about 29.9%. This combination is prompting some investors to reassess how the company’s network and cybersecurity business is currently being valued. See our latest analysis for...

Plexus Corp. recently reported past fiscal second-quarter 2026 results with sales of US$1,163.76 million and net income of US$49.81 million, alongside new third-quarter guidance calling for US$1.20 billion to US$1.25 billion in revenue and GAAP diluted EPS of US$1.25 to US$1.41. The company also announced a planned CFO transition, with long-serving finance chief Patrick Jermain retiring and internal executive David Abuhl stepping into the role, signaling continuity in financial leadership...

Last week, you might have seen that Microsoft Corporation ( NASDAQ:MSFT ) released its third-quarter result to the...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

UFP Industries, Inc. ( NASDAQ:UFPI ) just released its latest first-quarter report and things are not looking great. It...

Woodward, Inc. ( NASDAQ:WWD ) investors will be delighted, with the company turning in some strong numbers with its...

While Culp, Inc. ( NASDAQ:CULP ) might not have the largest market cap around , it received a lot of attention from a...

Some Northern Trust Corporation ( NASDAQ:NTRS ) shareholders may be a little concerned to see that the Executive VP...

Investors in Automatic Data Processing, Inc. ( NASDAQ:ADP ) had a good week, as its shares rose 9.0% to close at US$214...

Seanergy Maritime Holdings Corp. ( NASDAQ:SHIP ), is not the largest company out there, but it received a lot of...

Compañía de Minas BuenaventuraA (NYSE:BVN) reported multiple operational and permitting milestones in Q1 2026, including the production ramp up at San Gabriel. The company received key stage 1 operating and water use permits for San Gabriel, while Yumpag and El Brocal secured capacity expansion approvals. Gold production, company wide revenue, and profitability all saw significant gains in the quarter, alongside these project advances. For investors watching NYSE:BVN, these updates come...

In late April 2026, CoStar Group reported first-quarter 2026 revenue of US$897 million, up from US$732 million a year earlier, with net income of US$3 million versus a prior net loss, while reaffirming its full-year 2026 revenue outlook and projecting higher net income and diluted EPS. Beneath the headline numbers, management highlighted rapid growth and monetization at Homes.com and a doubling of adjusted EBITDA, signaling improving profitability from recent residential and technology...

Netflix, NasdaqGS:NFLX, has acquired InterPositive, a specialist in AI tools for filmmakers. The deal adds AI driven production capabilities that are intended to support more efficient content creation. The move aligns with Netflix’s focus on using technology in its streaming and studio operations. Netflix is trading at $92.06, with returns of 185.2% over three years and 82.7% over five years, alongside a 20.4% decline over the past year. The InterPositive acquisition comes as the company...

DraftKings stock performance snapshot With no specific news event driving trading today, DraftKings (DKNG) sits around a last close of US$23, giving the stock a market value near US$11.6b and putting recent returns in context. Over the past year, DraftKings has delivered a total return decline of about 33%, with year to date performance showing a similar 36% decline. The stock is roughly flat over the past month and down about 16% over the past 3 months. See our latest analysis for...

In recent days, Gorilla Technology Group Inc. announced a significant expansion of its India AI infrastructure collaboration with Yotta Data Services, supporting the deployment of 20,736 additional B300 GPU cards in a multi-year project valued at about US$2.80 billion, alongside a deeper investment in real-time infrastructure intelligence firm Astrikos.AI. This combination of a very large GPU deployment tied to one of APAC’s largest NVIDIA DGX Cloud clusters and closer Astrikos.AI...

Wondering whether Travere Therapeutics at around US$44.12 is still offering value or if the easy gains are already behind it? This article unpacks what the current price really implies. The stock has shown strong share price moves, with returns of 8.9% over 7 days, 40.4% over 30 days, 11.6% year to date, 108.6% over 1 year, 162.6% over 3 years and 120.5% over 5 years. This naturally raises questions about both upside potential and risk. Recent headlines around Travere Therapeutics have...